Actively Recruiting
MARINA Study Investigating Inflammation and Immune Biomarkers to Predict Severity and Treatment Response in Critically Ill Adults
Led by University of Turin, Italy · Updated on 2026-07-06
200
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the role of inflammatory and immune biomarkers in adults admitted to intensive care or step-down units with signs of active infection, including sepsis and septic shock. This observational study aims to evaluate how these biomarkers may help predict clinical severity, organ damage, response to treatment, and infectious complications in critically ill patients. The research focuses on three main groups those with suspected or confirmed infection, patients undergoing high-risk major surgery, and immunocompromised patients such as transplant recipients and those with severe immune suppression. Participants are observed without receiving experimental treatments. Biomarker measurements like procalcitonin, C-reactive protein, interleukin-6, troponin, and others are collected at specific times within 24 hours, within 72 hours, and on day 7 of ICU admission. Clinical data are integrated with these biomarker results on a dedicated electronic platform. The study plans to enroll at least 200 patients across centers in Italy and Spain over four years. During the study, participants undergo serial blood tests to measure biomarkers alongside clinical assessments of their condition, organ function, and infectious status. Researchers track outcomes including 28-day mortality, organ damage, treatment response, infectious complications, length of ICU and hospital stay, and survival at 90 and 180 days. The study collects detailed clinical and laboratory data to improve early risk stratification and support better management of critically ill patients.
CONDITIONS
Brief Title
BioMArkeRs of INflammation, Infection, and Immunity in the Critical Area (MARINA): the Use of Inflammatory and Immunity Biomarkers as Early Predictors of Clinical Severity, Organ Damage, Response to Treatment, and Infectious Complications in Patients Admitted to the Critical Care Area.
Research Team
G
Giorgia Montrucchio, Professor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here